Latest News for: copd
Edit
Dry Powder Inhalers: A Double Win for COPD and Environment
US News 24 Feb 2026
By Dennis Thompson HealthDay ReporterTUESDAY, Feb. 24, 2026 (HealthDay News) — Dry powder inhalers might provide a double benefit for people... .
Edit
Just Cough Into Your Phone: AI App Helps Screen Asthma, COPD In Minutes | Check Details
News18 19 Feb 2026
Edit
AI app analysing coughs could close COPD diagnostic gaps in primary care, AIIMS study shows
The Times of India 18 Feb 2026
Edit
GSK’s Arexvy associated with reductions in certain RSV-related risks including heart attack, stroke and severe flare-ups of COPD and asthma, real world study shows (GSK plc)
Public Technologies 17 Feb 2026
Edit
After Steve got breathless on short walks he was diagnosed with deadly COPD. Now he's ...
The Daily Mail 14 Feb 2026
When Steve Bowen became breathless on a short walk after picking up his grandson Riggs from school, he knew something was seriously wrong. His head was pounding ....
Edit
Fans mourn rock icon dead at 83 after COPD, heart failure battle: ‘Incredible talent’
Penn Live 08 Feb 2026
Chuck Negron, a founding member and frontman for the beloved rock band Three Dog Night, has died. He was 83. Deadline reported that Negron had been battling COPD and was also suffering from heart failure in recent months ... “Always loved his voice ... ....
Edit
Stopping COPD inhalers can lead to higher risk of flare-ups for 3 months (The University of Manchester)
Public Technologies 06 Feb 2026
Edit
Nucala (mepolizumab) approved by the European Commission for the treatment of chronic obstructive pulmonary disease (COPD) (Form 6-K) (GSK plc)
Public Technologies 06 Feb 2026
Nucala (mepolizumab) approved by the European Commission for the treatment of chronic obstructive pulmonary disease (COPD) ... Nucala is the first and only monthly biologic in the EU evaluated in a wide COPD population with an eosinophilic phenotype.
Edit
Natural ways to support lung health amid rising COPD concerns
Natural News 03 Feb 2026
Chronic obstructive pulmonary disease (COPD) caused 3.5 million deaths in 2021 (5% of global fatalities). Conventional treatments (bronchodilators... .
Edit
COPD Pipeline 2025: MOA and ROA Insights, Clinical Trials Status, and Key Companies Involved by ...
GetNews 20 Jan 2026
Edit
Worsening Air Quality Fuels Sales Of Asthma, COPD And Allergy Drugs: Data
News18 09 Jan 2026
Asthma, Chronic Obstructive Pulmonary Disease (COPD), allergy and nasal therapies see sustained growth amid severe to very poor AQI in urban centres along with seasonal infections ....
Edit
AirNexis Therapeutics Launches with $200M Series A to Advance Phase 2 Dual PDE3/4 Inhibitor AN01 for Chronic Obstructive Pulmonary Disease (COPD)
Pharmiweb 09 Jan 2026
Edit
Bambusa Therapeutics Announces First Patient Dosed in Phase Ib Proof-of-Concept COPD Study of BBT002, Reinforcing Bispecific Pipeline Momentum
PR Newswire 06 Jan 2026
Edit
MHRA authorises Nucala (mepolizumab) in the UK for the treatment of uncontrolled COPD of an eosinophilic phenotype for patients on triple therapy*
Pharmiweb 06 Jan 2026- 1
- 2
- Next page »